100 Participants NeededMy employer runs this trial

Decision Support Tool for Breast Cancer

(COAST Trial)

Recruiting at 3 trial locations
ZK
DD
Overseen ByDarima Dorzhieva
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Weill Medical College of Cornell University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a tool called COAST to determine if it improves communication between people with advanced breast cancer and their doctors regarding treatment decisions. The study will assess COAST's usability and integration into the care process at several hospitals in New York. Participants will complete two surveys and may participate in an interview. The trial seeks individuals with Stage IV breast cancer who speak English, Spanish, or Mandarin. As an unphased trial, participation offers an opportunity to contribute to the enhancement of communication tools for cancer care.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on improving communication rather than changing treatments.

What prior data suggests that the COAST decision support tool is safe for use in improving communication between patients and providers?

Research has shown that decision support tools, like the COAST tool under study, are generally safe. These tools assist with communication and decision-making in healthcare. They do not involve medication or medical procedures, so participants face no known physical side effects or risks. The COAST tool specifically aims to enhance conversations between patients and doctors about breast cancer care.

Studies on similar tools have demonstrated their helpfulness without causing harm. Participants typically find them easy to use and beneficial for understanding treatment options. Therefore, the COAST tool is expected to be well-received in terms of safety.12345

Why are researchers excited about this trial?

Researchers are excited about the COAST Decision Support Tool because it offers a personalized approach to breast cancer treatment decisions. Unlike traditional methods, which rely heavily on standard protocols and physician judgment, this tool uses advanced algorithms to analyze individual patient data and provide tailored treatment recommendations. This approach aims to empower patients with more informed choices and improve their engagement in their care, potentially leading to better outcomes and satisfaction.

What evidence suggests that the COAST tool is effective for improving communication in breast cancer care?

Research has shown that decision support tools, such as the COAST Decision Support Tool studied in this trial, can significantly aid breast cancer patients in making informed decisions. Studies have found that these tools enhance communication between patients and doctors, resulting in improved treatment choices. For instance, using these tools has been linked to better decision-making and reduced regret about treatment decisions. Consequently, the COAST tool in this trial might increase patients' confidence and satisfaction with their treatment plans. Additionally, decision support tools can reduce anxiety by providing clear information and options. Overall, these tools aim to simplify complex medical decisions and make them more informed.12367

Who Is on the Research Team?

SR

Shoshana Rosenberg, ScD, MPH

Principal Investigator

Weill Medical College of Cornell University

Are You a Good Fit for This Trial?

This trial is for adults diagnosed with advanced breast cancer, especially those whose cancer has spread to the spine. Participants should be able to communicate with their healthcare team and complete surveys.

Inclusion Criteria

I am 18 years old or older.
English, Spanish or Mandarin speaking
I have been diagnosed with Stage IV breast cancer.

Exclusion Criteria

I have early-stage breast cancer.
Individuals speaking languages other than English, Spanish, or Mandarin as their primary language

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants use the COAST decision support tool and complete a survey before and 2-4 weeks after using the tool

2-4 weeks
2 surveys (1 before, 1 after using COAST)

Follow-up

Participants are monitored for changes in communication and decision-making effectiveness

2-4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • COAST Decision Support Tool

Trial Overview

The study is testing a decision support tool called COAST, which helps patients and doctors have better conversations about care options. Participants will use the tool and fill out surveys before and after using it.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: COAST interventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

Gilead Sciences

Industry Sponsor

Trials
1,150
Recruited
878,000+
Daniel O'Day profile image

Daniel O'Day

Gilead Sciences

Chief Executive Officer since 2019

MBA from Columbia University

Dietmar Berger profile image

Dietmar Berger

Gilead Sciences

Chief Medical Officer

MD and PhD from Albert-Ludwigs University School of Medicine

Citations

Clinical Decision Support Systems in Breast Cancer - PMC

The incorporation of digital tools, such as CDSSs, using clinical outcome data can support the treatment decision process for breast cancer.

Decision Support Tool for Patients With Advanced Breast ...

The goal of this pilot study is to understand and improve the shared decision-making process between people with advanced breast cancer and ...

Breast Cancer Decision Support: Expert vs. Machine ...

Recently ML based CDSS have emerged as a transformative tool, offering the potential to enhance the efficiency of decision-making processes within MDTMs¹⁴.

A clinical decision support system for breast cancer treatment

CureMate is a clinical decision support system to assist in the selection of the first treatment step in breast cancer.

Decision Science Core Facility Resources

This page includes a list of decision support tools created by our group. The tools are organized across the cancer care continuum.

A Clinical Decision Support Tool to Predict Contralateral ...

We developed an easy-to-use web application that can estimate lifetime and age-conditional risks for both carriers of relatively common breast ...

Shared Decision-Making Tools | ASBrS

This conversation aid utilizes a unique Option Grid system to facilitate a shared decision making conversation between newly diagnosed breast cancer patients.